Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
News Release
Five Years of Funding the Future
Genex Announces 5th Annual Case Manager Scholarship Award RecipientsWAYNE, PA –June 27, 2016 – Investing in the future of
PDF
News Release
Press Release - RxRN
Workers' Comp
Article
StateWatch Summer 2016
Workers' Comp
News Release
Genex Services Acquires IME Leader Med-Eval
Agreement expands Genex's independent medical exams offering WAYNE, PA – June 1, 2016 – Genex Services, a leader
Workers' Comp
News Release
Genex's Patricia McFall Wins Case in Point Platinum Award
Case management prize is one of industry's highest honorsWAYNE,
Workers' Comp
Case Study
Nurses Week 2016
Case Management in Workers' Comp - What It Takes